MedPath

Nervagest

Brand Name: Nervagest

Generic Name: Pregabalin

Active
Registration Number

DR-XY44616

Dosage Form

Capsule

Issuance Date

August 20, 2024

Expiry Date

June 4, 2030

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength75 mg
PackagingAlu/Clear PVC Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antiepileptic
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

PregabalinActive
Monograph: Pregabalin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform